Jane Street Group, LLC Deciphera Pharmaceuticals, Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$6.87 - $11.11 $771,501 - $1.25 Million	-112,300 Reduced 84.18%	21,100 $196,000
Q4 2021 Feb 15, 2022	BUY	$7.7 - $37.13 $903,210 - $4.36 Million	117,300 Added 728.57%	133,400 $1.3 Million
Q3 2021 Nov 16, 2021	BUY	$26.46 - $37.15 $426,006 - $598,115	16,100 New	16,100 $547,000
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $297,843 - $436,345	-9,100 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$40.39 - $56.73 $129,248 - $181,536	3,200 Added 54.24%	9,100 $408,000
Q4 2020 Feb 17, 2021	BUY	$51.77 - $66.18 $305,443 - $390,462	5,900 New	5,900 $337,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.